Post-COVID-19 interstitial lung disease: A new treatment challenge in rheumatoid arthritis patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Post-COVID-19 interstitial lung disease: A new treatment challenge in rheumatoid arthritis patients

Published:2022-12 Issue:10 Volume:18 Page:625-626
ISSN:1699-258X
Container-title:Reumatología Clínica
language:en
Short-container-title:Reumatología Clínica

Author:

Morell-Hita Jose Luis,Rigual-Bobillo Juan A.,Macía-Villa Cristina C.^ORCID

Publisher

Elsevier BV

Subject

Rheumatology

Reference9 articles.

1. American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 1;Mikuls;Arthritis Rheumatol,2020

2. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry;Gianfrancesco;Ann Rheum Dis,2020

3. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry;Sparks;Ann Rheum Dis,2021

4. COVID-19 with rheumatic diseases: a report of 5 cases;Cheng;Clin Rheumatol,2020

5. The risk of hospitalized infection in patients with rheumatoid arthritis;Smitten;J Rheumatol,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP